Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triphala vs cetirizine in mild persistent allergic rhinitis
TCTR20191008005Phase 2Not yet recruiting
- Sponsor
- Department of Pharmacology, Faculty of Medicine, Chiang Mai University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of triphala and cetirizine in allergic rhinitis (AR) (2 arms), sponsored by Department of Pharmacology, Faculty of Medicine, Chiang Mai University. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
triphalacetirizine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20191008005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191008005.